<!–
<!–
<!– <!–
<!–
<!–
<!–
Novo Nordisk, the pharmaceutical giant, has revealed preliminary study results showing its weight-loss pill worked better than blockbuster injections.
Study participants taking the drug, called amyretin, lost 13 percent of their body weight in 12 weeks, surpassing the amount of weight lost with their Wegovy obesity vaccine, which was 6 percent over the same period of time. time.
The groundbreaking results, which have not yet been backed by strict scientific scrutiny, propelled the company to 12th place among the most valuable companies with a valuation of $566 billion, surpassing Tesla and Visa.
The Danish drugmaker, along with Eli Lilly, run what is essentially a duopoly in the obesity drug market, and both have struggled to meet growing demand for their highly effective monthly diet injections.
The obesity pill caused greater weight loss in the same 12-week period as the company’s innovative Wegovy injectable.
Jelly Roll rocked the stage on Friday night at the Stagecoach Festival.The singer, 39, who…
Dozens of men in Italy were seen presenting a fascist salute in honor of Italian…
One caveat: Cabela's frequently sells the pre-2018 model at a deep discount, but doesn't label…
Kulusevski and Maddison went down just before Arsenal counterattacked and scored.Michael Dawson believes Trossard's challenge…
The sound of a baby crying is the last thing new parents (and anyone sitting…
By Pranav Harish for WhatsNew2Day Australia Published: 10:33EDT, April 28, 2024 | Updated: 10:38EDT, April…